0001683168-23-007107.txt : 20231012 0001683168-23-007107.hdr.sgml : 20231012 20231012180009 ACCESSION NUMBER: 0001683168-23-007107 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230921 FILED AS OF DATE: 20231012 DATE AS OF CHANGE: 20231012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Charles Faith L. CENTRAL INDEX KEY: 0001853985 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39126 FILM NUMBER: 231323506 MAIL ADDRESS: STREET 1: ABEONA THERAPEUTICS INC. STREET 2: 1330 AVENUE OF THE AMERICAS - FLOOR 33 CITY: NEW YORK STATE: NY ZIP: 10019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CNS Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001729427 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 822318545 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: 1-800-946-9185 MAIL ADDRESS: STREET 1: 2100 WEST LOOP SOUTH STREET 2: SUITE 900 CITY: HOUSTON STATE: TX ZIP: 77027 4/A 1 ownership.xml X0508 4/A 2023-09-21 2023-09-25 0 0001729427 CNS Pharmaceuticals, Inc. CNSP 0001853985 Charles Faith L. C/O CNS PHARMACEUTICALS, INC. 100 WEST LOOP SOUTH, SUITE 900 HOUSTON TX 77027 1 0 0 0 0 Option to purchase common stock 1.09 2023-09-21 4 A 0 26315 A 2033-09-22 Common Stock 26315 29815 D The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date. The stock options were issued in connection with the reporting person's Board of Director services to the Company. This amendment is being filed solely to correct the number of shares of common stock underlying the reported option, and total number of derivative securities owned following the reported transaction. /s/ Christopher Downs, Attorney-in-fact 2023-10-12